Download full-text PDF

Source

Publication Analysis

Top Keywords

[tubal sterilization
4
sterilization surgical
4
surgical culdoscopy]
4
[tubal
1
surgical
1
culdoscopy]
1

Similar Publications

Young adults' access to contraception is shifting after the June 2022 United States Supreme Court decision. This concurrent mixed-methods study measured young adults' use of and perceptions about tubal sterilization and vasectomy after the leaked opinion in May 2022. Using national-level medical claims data from IQVIA, we conducted difference-in-differences analyses of tubal sterilizations and vasectomies by age and state policy; using open-text survey responses from national MyVoice surveys in 2022 and 2023, we thematically analyzed young adults' perspectives.

View Article and Find Full Text PDF
Article Synopsis
  • There is an increasing interest in vasectomies following the Supreme Court's Dobbs decision, highlighting their safety and cost-effectiveness compared to tubal sterilization.
  • Health care providers from Title X-funded clinics were interviewed to understand the cultural, gender, and political influences on men's decisions to seek vasectomies.
  • Key barriers identified included income challenges, language barriers, medical distrust, and traditional gender roles, but many men expressed a strong desire to take responsibility for contraception and contribute to reproductive health equity.
View Article and Find Full Text PDF
Article Synopsis
  • Serous tubal intraepithelial carcinoma (STIC) lesions are precursors to high-grade serous ovarian carcinomas, which have the highest mortality rates among gynecologic cancers, particularly affecting women with hereditary risk factors.
  • A 38-year-old woman of Nepalese descent was found to have a STIC lesion during an opportunistic salpingectomy performed for sterilization, highlighting the potential risks even in patients considered average risk for ovarian cancer.
  • While the SEE-FIM protocol, which is more sensitive for detecting STIC lesions, is typically not applied to average risk patients, implementing it could reduce missed diagnoses, although the costs and effort involved remain uncertain, especially among underrepresented populations.
View Article and Find Full Text PDF

Colombian consensus for the diagnosis, prevention, and management of Rhesus disease.

Rev Colomb Obstet Ginecol

September 2024

Unidad de Medicina Materno Fetal, Clínica Del Prado, Universidad CES. Medellín (Colombia); Fundared Materna. Bogotá (Colombia).

Article Synopsis
  • Aiming to standardize care for Rh-D negative pregnant women, a panel of 23 experts developed guidelines focused on prevention and management of Rh isoimmunization and related conditions to improve perinatal outcomes.* -
  • Utilizing a modified Delphi method, the panel assessed 22 questions across eight key areas, including Rh-D testing, prenatal care, and treatment strategies for affected fetuses, reaching an 80% consensus on recommendations.* -
  • Key recommendations include encouraging preconception consultations for Rh-D negative women, determining maternal Rh-D status during initial healthcare visits, and ascertaining the father's Rh-D status early in prenatal care.*
View Article and Find Full Text PDF
Article Synopsis
  • Proficiency in postpartum abdominal sterilization is essential for obstetrics and gynecology residents, as noted by the Council on Resident Education, but barriers limit access to such procedures.
  • The development of a realistic, low-cost 3D model aimed at enhancing residents' skills and confidence in performing postpartum tubal ligation (PTL) showed promising results, with significant improvement in confidence after simulations.
  • Twelve residents successfully practiced on the model, which was well-received for its realism, closely mimicking key anatomical structures and the challenges of a live procedure.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!